IBDEI1L7 ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,28169,1,4,0)
 ;;=4^682.2
 ;;^UTILITY(U,$J,358.3,28169,1,5,0)
 ;;=5^Cellulitis Of Trunk
 ;;^UTILITY(U,$J,358.3,28169,2)
 ;;=^271890
 ;;^UTILITY(U,$J,358.3,28170,0)
 ;;=070.1^^162^1792^25
 ;;^UTILITY(U,$J,358.3,28170,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28170,1,4,0)
 ;;=4^070.1
 ;;^UTILITY(U,$J,358.3,28170,1,5,0)
 ;;=5^Hepatitis A 
 ;;^UTILITY(U,$J,358.3,28170,2)
 ;;=^126486
 ;;^UTILITY(U,$J,358.3,28171,0)
 ;;=070.30^^162^1792^28
 ;;^UTILITY(U,$J,358.3,28171,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28171,1,4,0)
 ;;=4^070.30
 ;;^UTILITY(U,$J,358.3,28171,1,5,0)
 ;;=5^Hepatitis B, Acute
 ;;^UTILITY(U,$J,358.3,28171,2)
 ;;=^266626
 ;;^UTILITY(U,$J,358.3,28172,0)
 ;;=070.32^^162^1792^29
 ;;^UTILITY(U,$J,358.3,28172,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28172,1,4,0)
 ;;=4^070.32
 ;;^UTILITY(U,$J,358.3,28172,1,5,0)
 ;;=5^Hepatitis B, Chronic
 ;;^UTILITY(U,$J,358.3,28172,2)
 ;;=^303249
 ;;^UTILITY(U,$J,358.3,28173,0)
 ;;=070.51^^162^1792^31
 ;;^UTILITY(U,$J,358.3,28173,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28173,1,4,0)
 ;;=4^070.51
 ;;^UTILITY(U,$J,358.3,28173,1,5,0)
 ;;=5^Hepatitis C, Acute
 ;;^UTILITY(U,$J,358.3,28173,2)
 ;;=^266632
 ;;^UTILITY(U,$J,358.3,28174,0)
 ;;=070.54^^162^1792^32
 ;;^UTILITY(U,$J,358.3,28174,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28174,1,4,0)
 ;;=4^070.54
 ;;^UTILITY(U,$J,358.3,28174,1,5,0)
 ;;=5^Hepatitis C, Chronic
 ;;^UTILITY(U,$J,358.3,28174,2)
 ;;=^303252
 ;;^UTILITY(U,$J,358.3,28175,0)
 ;;=571.41^^162^1792^34
 ;;^UTILITY(U,$J,358.3,28175,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28175,1,4,0)
 ;;=4^571.41
 ;;^UTILITY(U,$J,358.3,28175,1,5,0)
 ;;=5^Hepatitis, Chronic Persist
 ;;^UTILITY(U,$J,358.3,28175,2)
 ;;=^259093
 ;;^UTILITY(U,$J,358.3,28176,0)
 ;;=571.1^^162^1792^35
 ;;^UTILITY(U,$J,358.3,28176,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28176,1,4,0)
 ;;=4^571.1
 ;;^UTILITY(U,$J,358.3,28176,1,5,0)
 ;;=5^Hepatitis, Etoh Acute
 ;;^UTILITY(U,$J,358.3,28176,2)
 ;;=^2597
 ;;^UTILITY(U,$J,358.3,28177,0)
 ;;=070.59^^162^1792^36
 ;;^UTILITY(U,$J,358.3,28177,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28177,1,4,0)
 ;;=4^070.59
 ;;^UTILITY(U,$J,358.3,28177,1,5,0)
 ;;=5^Hepatitis, Other Viral
 ;;^UTILITY(U,$J,358.3,28177,2)
 ;;=Hepatitis, Other Viral^266631
 ;;^UTILITY(U,$J,358.3,28178,0)
 ;;=V08.^^162^1792^23
 ;;^UTILITY(U,$J,358.3,28178,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28178,1,4,0)
 ;;=4^V08.
 ;;^UTILITY(U,$J,358.3,28178,1,5,0)
 ;;=5^HIV + Status (Asymptomatic)
 ;;^UTILITY(U,$J,358.3,28178,2)
 ;;=HIV + Status (Asymptomatic)^303392
 ;;^UTILITY(U,$J,358.3,28179,0)
 ;;=042.^^162^1792^24
 ;;^UTILITY(U,$J,358.3,28179,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28179,1,4,0)
 ;;=4^042.
 ;;^UTILITY(U,$J,358.3,28179,1,5,0)
 ;;=5^HIV Disease (Symptomatic)
 ;;^UTILITY(U,$J,358.3,28179,2)
 ;;=HIV Disease (symptomatic)^266500
 ;;^UTILITY(U,$J,358.3,28180,0)
 ;;=464.00^^162^1792^44
 ;;^UTILITY(U,$J,358.3,28180,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28180,1,4,0)
 ;;=4^464.00
 ;;^UTILITY(U,$J,358.3,28180,1,5,0)
 ;;=5^Laryngitis,Acute
 ;;^UTILITY(U,$J,358.3,28180,2)
 ;;=Acute Laryngitis^323469
 ;;^UTILITY(U,$J,358.3,28181,0)
 ;;=790.6^^162^1792^1
 ;;^UTILITY(U,$J,358.3,28181,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28181,1,4,0)
 ;;=4^790.6
 ;;^UTILITY(U,$J,358.3,28181,1,5,0)
 ;;=5^Abnormal LFT's
 ;;^UTILITY(U,$J,358.3,28181,2)
 ;;=^87228
 ;;^UTILITY(U,$J,358.3,28182,0)
 ;;=780.60^^162^1792^19
 ;;^UTILITY(U,$J,358.3,28182,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28182,1,4,0)
 ;;=4^780.60
 ;;^UTILITY(U,$J,358.3,28182,1,5,0)
 ;;=5^Fever
 ;;
 ;;$END ROU IBDEI1L7
